Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials

Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics. The post Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials appeared first on MedCity News.

Read More

Calculating Social Vulnerability Index by ZIP Code

A paper by Ng, Zhang and Kowal (2025) use the American Community Survey (ACS) data from 2016–2022 were used to construct Social Vulnerability Index (SVI).  SVI is calculated from 16 social determinants of health (SDoH) variables that are grouped into 4 themes: socioeconomic status, household characteristics, racial and ethnic minority status, and housing type &…

Read More

Progressives Seek Health Privacy Protections in California, But Newsom Could Balk

When patients walked into Planned Parenthood clinics, a consumer data company sold their precise locations to anti-abortion groups for targeted ads. When patients picked up prescriptions for testosterone replacement therapy, law enforcement retrieved their names and addresses without a warrant. And when a father was arrested by immigration authorities, agents allegedly accessed his personal information…

Read More

Links

Why were COVID trials so fast.Innovation without access? The growing tension in rare disease coverageWhy rent control failsSpending growth at the state levelScrewworms and flesh-eating bacteria.

Read More